Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 189

1.

Effect of microorganism Sporosarcina pasteurii on the hydration of cement paste.

Lee JC, Lee CJ, Chun WY, Kim WJ, Chung CW.

J Microbiol Biotechnol. 2015 Apr 15. [Epub ahead of print]

2.

Discovery of I-BRD9, a Selective Cell Active Chemical Probe for Bromodomain Containing Protein 9 Inhibition.

Theodoulou NH, Bamborough P, Bannister AJ, Becher I, Bit RA, Che KH, Chung CW, Dittmann A, Drewes G, Drewry DH, Gordon L, Grandi P, Leveridge M, Lindon M, Michon AM, Molnar J, Robson SC, Tomkinson NC, Kouzarides T, Prinjha RK, Humphreys PG.

J Med Chem. 2015 Apr 30. [Epub ahead of print]

PMID:
25856009
3.

Discovery and Characterization of GSK2801, a Selective Chemical Probe for the Bromodomains BAZ2A and BAZ2B.

Chen P, Chaikuad A, Bamborough P, Bantscheff M, Bountra C, Chung CW, Fedorov O, Grandi P, Jung D, Lesniak R, Lindon M, Müller S, Philpott M, Prinjha R, Rogers C, Selenski C, Tallant C, Werner T, Willson TM, Knapp S, Drewry DH.

J Med Chem. 2015 Apr 6. [Epub ahead of print]

PMID:
25799074
4.

Inhibition of PAD4 activity is sufficient to disrupt mouse and human NET formation.

Lewis HD, Liddle J, Coote JE, Atkinson SJ, Barker MD, Bax BD, Bicker KL, Bingham RP, Campbell M, Chen YH, Chung CW, Craggs PD, Davis RP, Eberhard D, Joberty G, Lind KE, Locke K, Maller C, Martinod K, Patten C, Polyakova O, Rise CE, Rüdiger M, Sheppard RJ, Slade DJ, Thomas P, Thorpe J, Yao G, Drewes G, Wagner DD, Thompson PR, Prinjha RK, Wilson DM.

Nat Chem Biol. 2015 Mar;11(3):189-91. doi: 10.1038/nchembio.1735. Epub 2015 Jan 26.

PMID:
25622091
5.

1,3-Dimethyl Benzimidazolones Are Potent, Selective Inhibitors of the BRPF1 Bromodomain.

Demont EH, Bamborough P, Chung CW, Craggs PD, Fallon D, Gordon LJ, Grandi P, Hobbs CI, Hussain J, Jones EJ, Le Gall A, Michon AM, Mitchell DJ, Prinjha RK, Roberts AD, Sheppard RJ, Watson RJ.

ACS Med Chem Lett. 2014 Sep 10;5(11):1190-5. doi: 10.1021/ml5002932. eCollection 2014 Nov 13.

PMID:
25408830
6.

Paclitaxel-incorporated nanoparticles using block copolymers composed of poly(ethylene glycol)/poly(3-hydroxyoctanoate).

Kim HY, Ryu JH, Chu CW, Son GM, Jeong YI, Kwak TW, Kim do H, Chung CW, Rhee YH, Kang DH, Kim HW.

Nanoscale Res Lett. 2014 Sep 24;9(1):525. doi: 10.1186/1556-276X-9-525. eCollection 2014.

7.

Kruidenier et al. reply.

Kruidenier L, Chung CW, Cheng Z, Liddle J, Che K, Joberty G, Bantscheff M, Bountra C, Bridges A, Diallo H, Eberhard D, Hutchinson S, Jones E, Katso R, Leveridge M, Mander PK, Mosley J, Ramirez-Molina C, Rowland P, Schofield CJ, Sheppard RJ, Smith JE, Swales C, Tanner R, Thomas P, Tumber A, Drewes G, Oppermann U, Patel DJ, Lee K, Wilson DM.

Nature. 2014 Oct 2;514(7520):E2. doi: 10.1038/nature13689. No abstract available.

PMID:
25279927
8.

Defensive mechanism in cholangiocarcinoma cells against oxidative stress induced by chlorin e6-based photodynamic therapy.

Lee HM, Chung CW, Kim CH, Kim do H, Kwak TW, Jeong YI, Kang DH.

Drug Des Devel Ther. 2014 Sep 18;8:1451-62. doi: 10.2147/DDDT.S62265. eCollection 2014.

9.

The discovery of I-BET726 (GSK1324726A), a potent tetrahydroquinoline ApoA1 up-regulator and selective BET bromodomain inhibitor.

Gosmini R, Nguyen VL, Toum J, Simon C, Brusq JM, Krysa G, Mirguet O, Riou-Eymard AM, Boursier EV, Trottet L, Bamborough P, Clark H, Chung CW, Cutler L, Demont EH, Kaur R, Lewis AJ, Schilling MB, Soden PE, Taylor S, Walker AL, Walker MD, Prinjha RK, Nicodème E.

J Med Chem. 2014 Oct 9;57(19):8111-31. doi: 10.1021/jm5010539. Epub 2014 Sep 24.

PMID:
25249180
10.

Evaluating the efficacy of the current diagnosis-related group reimbursement system for laparoscopic appendectomy at a single institute in Korea.

Yoo RN, Chung CW, Kim JW.

Ann Surg Treat Res. 2014 Sep;87(3):148-55. doi: 10.4174/astr.2014.87.3.148. Epub 2014 Aug 26. Erratum in: Ann Surg Treat Res. 2014 Oct;87(4):222.

11.

Health behaviors and risk factors associated with chronic kidney disease in Korean patients with diabetes: the Fourth Korean National Health and Nutritional Examination Survey.

Lee SJ, Chung CW.

Asian Nurs Res (Korean Soc Nurs Sci). 2014 Mar;8(1):8-14. doi: 10.1016/j.anr.2013.11.001. Epub 2013 Nov 27.

12.

Flexible and transparent polyimide films containing two-dimensional alumina nanosheets templated by graphene oxide for improved barrier property.

Tseng IH, Tsai MH, Chung CW.

ACS Appl Mater Interfaces. 2014 Aug 13;6(15):13098-105. doi: 10.1021/am502962b. Epub 2014 Jul 16.

PMID:
25029634
13.

[Structural equation modeling on contraception behavior of unmarried men and women in Korea: gender difference].

Hwang SW, Chung CW.

J Korean Acad Nurs. 2014 Apr;44(2):159-69. doi: 10.4040/jkan.2014.44.2.159. Korean.

14.

Risk factors for pannus formation in the post-bariatric surgery population.

Chung CW, Kling RE, Sivak WN, Rubin JP, Gusenoff JA.

Plast Reconstr Surg. 2014 May;133(5):623e-627e. doi: 10.1097/PRS.0000000000000101.

PMID:
24776564
15.

Lipo-poly(L-histidine) hybrid materials with pH-sensitivity, intracellular delivery efficiency, and intrinsic targetability to cancer cells.

Johnson RP, Jeong YI, John JV, Chung CW, Choi SH, Song SY, Kang DH, Suh H, Kim I.

Macromol Rapid Commun. 2014 May;35(9):888-94. doi: 10.1002/marc.201300892. Epub 2014 Mar 5.

PMID:
24596253
16.

The commonly used PI3-kinase probe LY294002 is an inhibitor of BET bromodomains.

Dittmann A, Werner T, Chung CW, Savitski MM, Fälth Savitski M, Grandi P, Hopf C, Lindon M, Neubauer G, Prinjha RK, Bantscheff M, Drewes G.

ACS Chem Biol. 2014 Feb 21;9(2):495-502. doi: 10.1021/cb400789e. Epub 2013 Dec 10.

PMID:
24533473
17.

Clinical characteristics of acute cholecystitis with elevated liver enzymes not associated with choledocholithiasis.

Song SH, Kwon CI, Jin SM, Park HJ, Chung CW, Kwon SW, Ko KH, Hong SP.

Eur J Gastroenterol Hepatol. 2014 Apr;26(4):452-7. doi: 10.1097/MEG.0000000000000053.

PMID:
24518492
18.

Mechanism of solid-state plasma-induced dewetting for formation of copper and gold nanoparticles.

Kwon SH, Choe HJ, Lee HC, Chung CW, Lee JJ.

J Nanosci Nanotechnol. 2013 Sep;13(9):6109-14.

PMID:
24205610
19.

Discovery of epigenetic regulator I-BET762: lead optimization to afford a clinical candidate inhibitor of the BET bromodomains.

Mirguet O, Gosmini R, Toum J, Clément CA, Barnathan M, Brusq JM, Mordaunt JE, Grimes RM, Crowe M, Pineau O, Ajakane M, Daugan A, Jeffrey P, Cutler L, Haynes AC, Smithers NN, Chung CW, Bamborough P, Uings IJ, Lewis A, Witherington J, Parr N, Prinjha RK, Nicodème E.

J Med Chem. 2013 Oct 10;56(19):7501-15. doi: 10.1021/jm401088k. Epub 2013 Sep 25.

PMID:
24015967
20.

BET inhibition silences expression of MYCN and BCL2 and induces cytotoxicity in neuroblastoma tumor models.

Wyce A, Ganji G, Smitheman KN, Chung CW, Korenchuk S, Bai Y, Barbash O, Le B, Craggs PD, McCabe MT, Kennedy-Wilson KM, Sanchez LV, Gosmini RL, Parr N, McHugh CF, Dhanak D, Prinjha RK, Auger KR, Tummino PJ.

PLoS One. 2013 Aug 23;8(8):e72967. doi: 10.1371/journal.pone.0072967. eCollection 2013.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk